Clinical Trial Update: DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial evaluating DLBS1033 for Acute Non-ST Elevation Myocardial Infarction without early coronary revascularization has been withdrawn from Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st Elevation Myocardial Infarction

Drugs mentioned

• DLBS1033 (DLBS1033)

Snippet

Sponsor: Dexa Medica Group | Conditions: Acute Non-ST Elevation Myocardial Infarction | Phase 2, Phase 3 | Status: WITHDRAWN